Postdoc in Targeted In Vivo Delivery of Oligonucleotide (siRNA/ASO) Conjugates
- Deadline
- 2 Dec 2026 · 10 days left
- Location
- Huddinge, Sweden
- Type
- Postdoc
- Compensation
- Individual monthly salary under RALS / RALS-T
- Working language
- English
- Posted
- 22 Nov 2026
- Verified
- 22 Nov 2026
About this opportunity
Karolinska Institutet's Department of Laboratory Medicine is hiring a full-time postdoctoral researcher for its Division of Biomolecular and Cellular Medicine at the Flemingsberg campus in Huddinge, Sweden. You would join Professor Samir El Andaloussi's group, which works on getting biological drugs to target tissues in vivo, especially tissues outside the liver. The project centres on designing oligonucleotide conjugates (siRNAs and ASOs) that reach specific organs, and testing them.
What is offered
- A fixed-term, full-time (100%) postdoctoral position. The ad does not say how long it lasts.
- A monthly salary, set individually under the RALS and RALS-T collective agreements. No amount is given.
- Start date by agreement.
- Research tasks include:
- designing and carrying out strategies for targeted delivery of ASOs and siRNAs;
- evaluating targeting ligands and conjugation chemistries for organ- and tissue-specific RNA conjugates;
- leading the biological evaluation of the conjugates, including developing and optimising activity assays;
- comparing activity and tissue selectivity across organs, and studying how physicochemical properties affect distribution and function;
- linking conjugate design to delivery efficiency in in vitro and in vivo models, including animal studies.
Who can apply
- You must have a PhD, or a foreign degree judged equivalent to a Swedish doctorate, by the time the employment decision is made.
- A PhD completed within the last three years counts in your favour. Exceptions can be made for special reasons.
- In vitro characterisation: methods for physicochemical properties (e.g. CAC analysis, DLS, albumin/serum protein binding) and screening models for potency and delivery. Experience studying uptake and endosomal escape is a plus.
- Laboratory animal science: extensive hands-on work with mice, including IV and IP administration and relevant surgery. You should have planned single- and repeat-dose studies with tissue collection from several organs, have documented experience of oligonucleotide biodistribution studies in mice, and know animal ethics and welfare rules. Stereotaxic surgery, toxicity studies and in vivo imaging (IVIS, bioluminescence, fluorescence) are a plus.
- Molecular and cell biology: mammalian cell culture and transient transfection, tissue homogenisation and RNA isolation, and RT-qPCR, dPCR and SplintR. Flow cytometry, cell sorting and RNA sequencing are a plus.
- Very good spoken and written English, good teamwork and communication skills, the ability to work independently, and careful documentation habits.
How to apply
- Apply through KI's Varbi recruitment system by 2 December 2026.
- Documents can be in English or Swedish:
- proof of your doctoral degree;
- a full CV, including your defence date, thesis title, previous academic positions, current position, academic awards and committee work;
- a full publication list;
- a summary of your current work (one page at most).
- Questions about the role: Professor Samir El Andaloussi, samir.el-andaloussi@ki.se.
- Reference number: STÖD 2-4644/2026.
Requirements
-
Open to all nationalities
-
Early-career researcher
-
Minimum degree: PhD
Postdoc in Targeted In Vivo Delivery of Oligonucleotide (siRNA/ASO) Conjugates
2 Dec 2026 · 10 days left